Stuart Chaffee

Company: QuantX Biosciences

Job title: CEO

Seminars:

Uncovering Modality, Precision Targeting & Global Partnership Synergies to Advance Autoimmune Combination Therapy Innovations 3:00 pm

Discussing optimal modality combinations, considering checkpoint agonism, bispecific, monoclonal and fixed dose oral approaches, to safety tailor combinations for complex autoimmune diseases, including IBD and RA Evaluating the balance of known and novel targets to align with safety profiles and unmet patient needs Exploring partnership opportunities with the rapidly expanding bispecific market in Asia and…Read more

day: Day Two

OUR CONTACT DETAILS

Phone
UK: +44 (0)20 3141 8700
US: +1 617 455 4188

Email
info@hansonwade.com

JOIN OUR TEAM

We are always looking for ambitious people to join our team. You'll have opportunities to learn quickly, advance your career, and to meaningfully impact our customers and our business.

Click here to learn about careers.

ABOUT US

Hanson Wade specializes in scientific research across a comprehensive range of distinctive R&D areas. We deliver insight and connections to facilitate safe and effective drug development for more personalized and targeted patient populations.

EXPLORE OUR PRODUCTS

 

Conferences Beacon
Intelligence

SEARCH

ORGANIZED BY

Terms & Conditions

Privacy Policy

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.